1. Autism Spectrum Disorders
At the conclusion of this presentation, the participant will be able to:
- Define Autism Spectrum Disorders
- Identify known causes of ASD
- Discuss and implement assessment tools necessary to diagnose ASD
- Discuss management options for ASD
2. Benign Prostatic Hyperplasia
At the conclusion of this presentation, the participant will be able to:
- Understand prevalence and pathophysiology of Benign Prostatic Hyperplasia (BPH)
- Understand the pertinent history, physical exam, and laboratory diagnosis
- Discuss medical and surgical management options for BPH
- Understand the rationale and strategy for combination alpha blocker and 5 alpha-reductase therapy
- Understand the comorbidity between BPH and Overactive Bladder (OAB)
- Discuss when to refer to specialty care
3. Central Precocious Puberty
At the conclusion of this session, the participant will be able to:
- Define abnormal findings associated with Central Precocious Puberty
- Discuss the pathophysiology of Central Precocious Puberty
- Discuss risks associated with and the prognosis of a positive diagnosis
- Discuss appropriate work-up of suspected Precocious Puberty
- Discuss standard-of-care pharmacologic and non-pharmacologic treatment options
4. Diabetes From a Different Point of View
At the conclusion of this session, the participant will be able to:
- Explain the rationale for intensive therapy in patients with type 2 diabetes
- Discuss the use of the various insulin formulations in the overall management of Type 2 Diabetes
- Discuss how to initiate and optimize physiologic insulin therapy using a case presentation
- Enhance clinicians’ skills in managing patients with type 2 diabetes on insulin therapy
5. Emerging Dangers – An Update on Resistant Bacterial Strains
At the conclusion of this session, participants will be able to:
- Discuss newly identified emerging resistant bacterial strains
- Identify signs and symptoms of each bacterial strain
- Identify at-risk patient populations for each bacterial strain
- Discuss appropriate evaluation methods, treatment options and preventive measures for each bacterial strain
6. The Evaluation and Management of Anaphylaxis
At the conclusion of this session, participants will be able to:
- Review common signs and symptoms of Anaphylaxis
- Review the most common causes of Anaphylaxis
- Discuss appropriate emergent treatment options for Anaphylaxis
- Discuss appropriate workup of and management of Anaphylaxis
7. The Evaluation and Management of Multiple Sclerosis
At the conclusion of this session, participants will be able to:
- Review common signs and symptoms of Multiple Sclerosis
- Discuss basic pathophysiology of disease process
- Discuss appropriate tests and procedures to assist with diagnosis
- Review pharmacologic and non-pharmacologic treatment options
8. Fibromyalgia: A Holistic Approach
At the conclusion of this session, participants will be able to:
- Identify signs and symptoms of Fibromyalgia
- Discuss differential diagnoses of signs and symptoms
- Discuss appropriate workup of Fibromyalgia patient
- Discuss pharmacologic and non-pharmacologic treatment options
9. Hyperlipidemia – Treatment Beyond LDL
At the conclusion of this session, the participant will be able to:
- Discuss the pathophysiology of mixed Hyperlipidemia
- Discuss morbidity and mortality associated with Hyperlipidemia
- Review patient population at risk for Hyperlipidemia
- Discuss appropriate work-up of the patient with Hyperlipidemia
- Discuss pharmacologic and non-pharmacologic therapeutic options
- Review accepted benchmarks in long-term management
10. The Implications of Renal Disease
At the conclusion of this session, the participant will be able to:
- Differentiate between renal insufficiency and renal failure
- Differentiate between acute and chronic renal failure
- Discuss the progression of renal failure from chronic to end-stage renal failure
- Discuss pharmacologic and non-pharmacologic therapeutic options
- Discuss preventive measures and long-term management benchmarks
11. Metabolic Syndrome
At the conclusion of this session, the participant will be able to:
- Identify Risk Factors for Metabolic Syndrome
- Able to describe the Diagnostic Criteria
- Have a better understanding of Management and Preventative Strategies
12. Prescribing Pitfalls
At the conclusion of this session, the participant will be able to:
- Describe the prevalence of medication prescribing errors and its contribution to drug-related morbidity, patient injury and professional liability
- Understand the application of federal and state laws that govern medication prescribing
- List common prescribing errors and omissions
- Describe strategies designed to minimize risk of civil, disciplinary and/or criminal liability that may result from medication prescribing
13. The Successful Preceptor
At the conclusion of this session, the participant will be able to:
- Utilize the Five Minute Preceptor to enable positive learning in the PA student
- Discuss the steps in using a method of precepting students to allow for maximum use of time in preceptor-student encounters
- Identify successful attributes of the teacher in the clinical setting
14. What Every Clinician Should Know About Brain Injuries:
At the conclusion of this session, the participant will be able to:
- Identify signs and symptoms of Brain Injury, i.e. acute vs. chronic symptoms
- Review the classification of Brain Injury and the Rancho Los Amigos Scale
- Discuss the management principles in acute/chronic Brain Injury
- The importance of the team approach
- The emerging role of medication in the management of Brain Injury
- Discuss trends of a growing epidemic
- Advances in trauma care
- The impact of the Iraq War on the health industry
|
